Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
However, given our effects with two classes of drugs as well as cross sectional, between subjects findings, the decrease in drinking observed here is unlikely due to reporting biases alone
Glucagonlike peptide1 receptor agonists in type 2 diabetes treatment: are they all the same
PubMed PMID: 25117994
Additional information Digital Features To view digital features for this article go to Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
US$ 23.08
US$ 22.74
US$ 22.14
US$ 20.39
US$ 29.05
US$ 24.65
